GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Short Interest

Q-linea AB (OSTO:QLINEA) Short Interest


View and export this data going back to 2018. Start your Free Trial

What is Q-linea AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Q-linea AB's Short Interest

For the Medical Devices subindustry, Q-linea AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q-linea AB's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Q-linea AB's Short Interest falls into.


;
;

Q-linea AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Short Interest
Comparable Companies
OSTO:SPEC OSTO:NOSA OSTO:DIGN OSTO:NEOLA OSTO:SCIB NGM:MCLR XSAT:BIBB OSTO:ARCOMA OSTO:ACARIX XSAT:REDS ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
3F8:Germany
Address
Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Website
https://www.qlinea.com
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.

Q-linea AB Headlines

No Headlines